This is supported by studies demonstrating increased activities of VEGFR-3-stimulated LECs [10], correlation of overexpressed VEGF-C/-D in tumor cells with increased LVD and LN metastasis [11], and suppression of tumor lymphatic formation by inhibitors of VEGFR-3 or its ligands [12,13]. Here, FLT4 is linked to neoplasm.